A Trial of SHR-1802 in Patients With Failure of Standard Treatment for Advanced Malignant Tumours

NCT04414150 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Tumours

Interventions

DRUG: SHR-1802

Sponsor

Jiangsu HengRui Medicine Co., Ltd.